(RXO) RXO - Overview
Stock: Truck Brokerage, Managed Transportation, Last Mile, Freight Forwarding
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 77.3% |
| Relative Tail Risk | -11.6% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.44 |
| Alpha | -68.77 |
| Character TTM | |
|---|---|
| Beta | 2.037 |
| Beta Downside | 2.132 |
| Drawdowns 3y | |
|---|---|
| Max DD | 67.15% |
| CAGR/Max DD | -0.12 |
Description: RXO RXO January 12, 2026
RXO, Inc. (NYSE:RXO) operates an asset-light truck brokerage platform across North America, Asia, and Europe, matching shippers with carriers for full-truckload freight. In addition to brokerage, the firm offers managed transportation, last-mile delivery, and freight-forwarding services that include ocean/air booking, customs brokerage, and domestic ancillary logistics. The company was spun out and incorporated in 2022 and is headquartered in Charlotte, North Carolina.
Key operating metrics that analysts watch include: (1) **Revenue growth** of ~12% YoY in Q4 2023, driven by higher freight volumes and price-to-cost gains; (2) **EBITDA margin** hovering around 7% after scaling its technology stack, which is modest but improving relative to the 5% average in the broader cargo-ground transportation sub-industry; and (3) **Load-to-capacity utilization** of roughly 78%, reflecting ongoing driver-shortage constraints that keep spot-rate premiums elevated. Macro-level drivers such as sustained e-commerce demand, a tight capacity market, and volatile fuel prices remain material to RXO’s top-line outlook.
If you want a data-rich, independent assessment of RXO’s valuation and risk profile, a quick look at the ValueRay research page could be a useful next step.
Piotroski VR‑10 (Strict, 0-10) 3.0
| Net Income: -79.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.01 > 0.02 and ΔFCF/TA 0.53 > 1.0 |
| NWC/Revenue: 4.95% < 20% (prev 7.98%; Δ -3.03% < -1%) |
| CFO/TA 0.01 > 3% & CFO 37.0m > Net Income -79.0m |
| Net Debt (657.0m) to EBITDA (124.0m): 5.30 < 3 |
| Current Ratio: 1.32 > 1.5 & < 3 |
| Outstanding Shares: last quarter (168.6m) vs 12m ago 25.72% < -2% |
| Gross Margin: 16.53% > 18% (prev 0.18%; Δ 1635 % > 0.5%) |
| Asset Turnover: 180.2% > 50% (prev 113.8%; Δ 66.36% > 0%) |
| Interest Coverage Ratio: 0.09 > 6 (EBITDA TTM 124.0m / Interest Expense TTM 34.0m) |
Altman Z'' 0.04
| A: 0.09 (Total Current Assets 1.20b - Total Current Liabilities 907.0m) / Total Assets 3.20b |
| B: -0.11 (Retained Earnings -338.0m / Total Assets 3.20b) |
| C: 0.00 (EBIT TTM 3.00m / Avg Total Assets 3.30b) |
| D: -0.21 (Book Value of Equity -348.0m / Total Liabilities 1.62b) |
| Altman-Z'' Score: 0.04 = B |
Beneish M -2.89
| DSRI: 0.63 (Receivables 1.10b/1.14b, Revenue 5.94b/3.86b) |
| GMI: 1.07 (GM 16.53% / 17.77%) |
| AQI: 1.05 (AQ_t 0.50 / AQ_t-1 0.48) |
| SGI: 1.54 (Revenue 5.94b / 3.86b) |
| TATA: -0.04 (NI -79.0m - CFO 37.0m) / TA 3.20b) |
| Beneish M-Score: -2.89 (Cap -4..+1) = A |
What is the price of RXO shares?
Over the past week, the price has changed by +2.58%, over one month by +20.64%, over three months by -12.09% and over the past year by -37.13%.
Is RXO a buy, sell or hold?
- StrongBuy: 3
- Buy: 1
- Hold: 14
- Sell: 1
- StrongSell: 2
What are the forecasts/targets for the RXO price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 15.5 | 0.1% |
| Analysts Target Price | 15.5 | 0.1% |
| ValueRay Target Price | 14.7 | -5% |
RXO Fundamental Data Overview February 03, 2026
P/S = 0.4028
P/B = 1.5456
P/EG = 20.2449
Revenue TTM = 5.94b USD
EBIT TTM = 3.00m USD
EBITDA TTM = 124.0m USD
Long Term Debt = 387.0m USD (from longTermDebt, last quarter)
Short Term Debt = 93.0m USD (from shortTermDebt, last quarter)
Debt = 682.0m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 657.0m USD (from netDebt column, last quarter)
Enterprise Value = 3.05b USD (2.39b + Debt 682.0m - CCE 25.0m)
Interest Coverage Ratio = 0.09 (Ebit TTM 3.00m / Interest Expense TTM 34.0m)
EV/FCF = -169.4x (Enterprise Value 3.05b / FCF TTM -18.0m)
FCF Yield = -0.59% (FCF TTM -18.0m / Enterprise Value 3.05b)
FCF Margin = -0.30% (FCF TTM -18.0m / Revenue TTM 5.94b)
Net Margin = -1.33% (Net Income TTM -79.0m / Revenue TTM 5.94b)
Gross Margin = 16.53% ((Revenue TTM 5.94b - Cost of Revenue TTM 4.96b) / Revenue TTM)
Gross Margin QoQ = 16.61% (prev 17.90%)
Tobins Q-Ratio = 0.95 (Enterprise Value 3.05b / Total Assets 3.20b)
Interest Expense / Debt = 1.32% (Interest Expense 9.00m / Debt 682.0m)
Taxrate = 21.0% (US default 21%)
NOPAT = 2.37m (EBIT 3.00m * (1 - 21.00%))
Current Ratio = 1.32 (Total Current Assets 1.20b / Total Current Liabilities 907.0m)
Debt / Equity = 0.43 (Debt 682.0m / totalStockholderEquity, last quarter 1.58b)
Debt / EBITDA = 5.30 (Net Debt 657.0m / EBITDA 124.0m)
Debt / FCF = -36.50 (negative FCF - burning cash) (Net Debt 657.0m / FCF TTM -18.0m)
Total Stockholder Equity = 1.59b (last 4 quarters mean from totalStockholderEquity)
RoA = -2.40% (Net Income -79.0m / Total Assets 3.20b)
RoE = -4.96% (Net Income TTM -79.0m / Total Stockholder Equity 1.59b)
RoCE = 0.15% (EBIT 3.00m / Capital Employed (Equity 1.59b + L.T.Debt 387.0m))
RoIC = 0.12% (NOPAT 2.37m / Invested Capital 1.99b)
WACC = 10.67% (E(2.39b)/V(3.07b) * Re(13.42%) + D(682.0m)/V(3.07b) * Rd(1.32%) * (1-Tc(0.21)))
Discount Rate = 13.42% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 18.74%
Fair Price DCF = unknown (Cash Flow -18.0m)
EPS Correlation: -42.21 | EPS CAGR: -6.57% | SUE: -0.06 | # QB: 0
Revenue Correlation: 22.24 | Revenue CAGR: 1.84% | SUE: -0.27 | # QB: 0
EPS next Quarter (2026-03-31): EPS=-0.06 | Chg30d=-0.012 | Revisions Net=-8 | Analysts=14
EPS next Year (2026-12-31): EPS=0.10 | Chg30d=-0.078 | Revisions Net=-12 | Growth EPS=+863.1% | Growth Revenue=+3.1%